Large-Bore Vascular Closure Device
Closure of femoral artery access sites (12F-24F) post structural heart and endovascular procedures
Key Facts
About Spiorad Medical
Spiorad Medical is a private, pre-revenue medical device startup targeting the vascular closure market, with a focus on large-bore access. Its core technology is a proprietary device intended to close large femoral arteriotomies created during procedures like transcatheter aortic valve implantation (TAVI) and complex endovascular aortic repair. The company is led by a CEO with commercial experience from major medtech firms and a Chief Medical Officer who is a practicing interventional cardiologist, providing strong clinical and market insight. Spiorad appears to be in the development and pre-clinical validation stage, supported by awards and collaborations within the Irish and European innovation ecosystem.
View full company profile